The new concept: EMIT - CANCER IS CURABLE
In the course of approximately 30 years in cancer research (see curriculum vitae) I have been trying to work out a new strategy to overcome the problems mentioned above. Based on my observations I assume that the mode of therapy should comprise not only the destruction of the tumor cell, but should focus on its “conversion”, “re-education” into normal functioning body cells. I frequently observed that cancer cells have the same “instincts” or will to survive as any other organism; it is amazing how these cells strive to survive at any rate. But at the same time they destroy their hosting body: Isn’t this some sort of suicide? If yes, this would be an unexplainable paradoxon which is absolutely against the natur´s logic.
If activated properly, our immune system provides a powerful weapon against cancer. The pictures above convincingly demonstrate its efficacy: The successful treatment of this patient, suffering from disseminated Kaposi Sarcoma, was not the merit of radiation or chemotherapy, but was due to his faith in a mode of immunological treatment which is referred to as EMIT. During the whole period of treatment no adverse effect was reported except increased vital activity in every field of life (see more images).
Though the patient presented above is best suited for documentation by means of photography, the EMIT effect could obviously be observed in a patient suffering from renal cell carcinoma. In addition, the biological mechanism of action of EMIT could impressively be demonstrated with the cells of other patients in vitro as well (see images).
In the light of the above-mentioned case, the question arises inevitably: Is cancer curable through immune therapy? The course of this patient´s illness justifies the answer: In all probability, thanks to EMIT CANCER IS CURABLE.
Generally speaking, the diagnosis “cancer” is regarded as a terrible fate and, in particular, a death sentence. Therefore, one could believe that humanity is waiting for a feasible solution. But there are too many incredible obstacles as discussed below.
For decades, an unfortunate alliance between politics and business has implemented many regulations, which are not always reasonable, under the guise of “Quality Assurance in Medicine”. Too often, this argument serves to conceal concrete economic interests, which is why innovative ideas are often nipped in the bud.
Dr. med. Sadık Öz, Feuerweg 21, 90443 Nürnberg, +49 911 92919620
Tel. + 49 9123 14957
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The new concept: EMIT - CANCER IS CURABLE here
News-ID: 326766 • Views: 567
More Releases from PBirkel
Extracorporal Modified Immune Therapy (EMIT)
A tumor patient usually does not die from a benign tumor, but from a malignant tumor that maintains an uninhibited proliferation, which in turn interferes fatally with the vital functions of other organs. Apart from surgical procedures at an early stage, conventional cancer therapy is based on the philosophy that cancer cells should be destroyed with various destructive methods such as chemotherapy, radiation therapy, TKI, monoclonal antibodies, etc. All immunological research
An alternative cancer treatment: Extracorporal Modified Immune Therapy (EMIT)
EMIT is based on the special cultivation of somatic tumor cells and leucocytes of patients, it would be subject to such regulation, too. Due to such financial and administrative obstacles it is almost impossible to offer this promising treatment for public use. If a physician acts against these regulations, this would be regarded as an indictable offence as mentioned above. Moreover, other problems emerge: Those who do not belong to academic
May renal cell carcinoma be cured by EMIT?
A 50 year-old male patient asked for help: A left-sided renal mass had been detected in an abdominal CT-scan performed due to a preceding gross hematuria. Abdominal CT-scan: Inhomogeneous tumor with a diameter of approximately 9.5 cm in the left kidney. Additionally, several enlarged aortic lymph nodes (about 8 mm in size) as well as a tumor in the left adrenal with a diameter of 10 mm. Pathological evaluation Macroscopy: Left kidney,